STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR - LOCATION OF THE FACTOR VIIA BINDING-SITE

被引:135
作者
MULLER, YA [1 ]
ULTSCH, MH [1 ]
KELLEY, RF [1 ]
DEVOS, AM [1 ]
机构
[1] GENENTECH INC,DEPT PROT ENGN,S SAN FRANCISCO,CA 94080
关键词
D O I
10.1021/bi00202a003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tissue factor, the obligate cofactor for coagulation factor VII, plays an essential role in hemostasis by initiating the extrinsic pathway of blood coagulation upon vascular damage, making it a promising target for new anticoagulant therapies in the treatment of thrombosis and sepsis. The three-dimensional structure of the extracellular domain of tissue factor, determined by X-ray crystallography at a resolution of 2.4 Angstrom, consists of two domains of approximately equal size, with a topology characteristic of fibronectin type III modules. Comparison of tissue factor with the extracellular domain of the growth hormone receptor, which belongs to the same receptor superfamily, shows that the relative orientation between these domains as well as the domain-domain interface is very different. These differences have dramatic consequences for the residues in tissue factor that are homologous to the binding determinants of the growth hormone receptor. Alanine-scanning mutagenesis has identified tissue factor residues important for factor VIIa binding. The structure shows that the binding site is located in the domain-domain interface region but on the opposite side of the molecule compared to the growth hormone receptor, with the binding determinants residing on beta-strands rather than on loops.
引用
收藏
页码:10864 / 10870
页数:7
相关论文
共 55 条
[1]   H-1-NMR ASSIGNMENT AND SECONDARY STRUCTURE OF THE CELL-ADHESION TYPE-III MODULE OF FIBRONECTIN [J].
BARON, M ;
MAIN, AL ;
DRISCOLL, PC ;
MARDON, HJ ;
BOYD, J ;
CAMPBELL, ID .
BIOCHEMISTRY, 1992, 31 (07) :2068-2073
[2]   A SYSTEMATIC MUTATIONAL ANALYSIS OF HORMONE-BINDING DETERMINANTS IN THE HUMAN GROWTH-HORMONE RECEPTOR [J].
BASS, SH ;
MULKERRIN, MG ;
WELLS, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (10) :4498-4502
[4]   THE CONTRIBUTIONS OF CA-2+, PHOSPHOLIPIDS AND TISSUE-FACTOR APOPROTEIN TO THE ACTIVATION OF HUMAN BLOOD-COAGULATION FACTOR-X BY ACTIVATED FACTOR-VII [J].
BOM, VJJ ;
BERTINA, RM .
BIOCHEMICAL JOURNAL, 1990, 265 (02) :327-336
[5]   CRYSTALLIZATION AND PRELIMINARY-X-RAY ANALYSIS OF HUMAN TISSUE FACTOR EXTRACELLULAR DOMAIN [J].
BOYS, CWG ;
MILLER, A ;
HARLOS, K ;
MARTIN, DMA ;
TUDDENHAM, EGD ;
OBRIEN, DP .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 234 (04) :1263-1265
[6]   CRYSTALLOGRAPHIC R-FACTOR REFINEMENT BY MOLECULAR-DYNAMICS [J].
BRUNGER, AT ;
KURIYAN, J ;
KARPLUS, M .
SCIENCE, 1987, 235 (4787) :458-460
[7]  
BRUNGER AT, 1990, XPLOR MANUAL
[8]   BUILDING PROTEINS WITH FIBRONECTIN TYPE-III MODULES [J].
CAMPBELL, ID ;
SPITZFADEN, C .
STRUCTURE, 1994, 2 (05) :333-337
[9]   THE COAGULATION CASCADE - INITIATION, MAINTENANCE, AND REGULATION [J].
DAVIE, EW ;
FUJIKAWA, K ;
KISIEL, W .
BIOCHEMISTRY, 1991, 30 (43) :10363-10370
[10]   ANTIBODY-ANTIGEN COMPLEXES [J].
DAVIES, DR ;
PADLAN, EA ;
SHERIFF, S .
ANNUAL REVIEW OF BIOCHEMISTRY, 1990, 59 :439-473